China Implements the Newly Released Good Pharmacovigilance Practice

by Grace Wang May 28, 2021

China National Medical Products Administration (NMPA) officially issued the Good Pharmacovigilance Practice (GVP) on May 13, 2021, after releasing the consultation draft in December last year. GVP, made for regulating and guiding pharmacovigilance activities, is set to come into enforcement on Dec. 1, 2021.

Grace Wang
ChemLinked Regulatory Analyst
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact